NYSEARCA:XBI

Spdr S&p Biotech Etf ETF News

etoro logo Buy XBI
*Your capital is at risk
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026

Biotech ETF nears a six-month low

09:45am, Monday, 13'th Mar 2023
Shares of the SPDR S&P Biotech ETF XBI tumbled toward a six-month low last week, closing at $75.66 on Friday, over concerns about biotech exposure to Silicon Valley Bank, which is owned by SVB Financi
The latest earnings from some of the big biotech players came in at mixed this reporting season.
Growth stock TG Therapeutics has surged 80% after FDA approval for its multiple sclerosis treatment. The post Biotech Growth Stock Boosted By FDA Approval For Multiple Sclerosis Treatment appeared fir
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innovation in obesity drugs, and acquisition
The "Halftime Report" traders give their top picks to watch for the second half.
A Golden Cross is a simple, yet effective technical indicator. Andrew Rocco explains how to use it and relates it back to the current market.

2 ETFs That Can Set You Up for Life

06:05am, Wednesday, 25'th Jan 2023
Simplifying your investment strategy can help minimize your risk while still allowing you to earn some great returns.
Smart Beta ETF report for XBI
Sector ETF report for XBI

Can Health Care Stocks Outperform Again In 2023?

06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

3 Unstoppable ETFs to Stock Up On in 2023

05:55am, Monday, 09'th Jan 2023
These ETFs could be big winners in the new year.
If there's one biotech area to watch in 2023, it's genetic medicine, like CRISPR. But other trends also point to a big year for biotech stocks.

6 ETF Predictions for 2023

09:02am, Thursday, 05'th Jan 2023
Wall Street had a shaky start to 2023 after the S&P 500's worst year since 2008. For Investors, we thus have jotted down a few predictions for 2023.
The biotech sector has been outperforming the major U.S. indices for the past few months. Can the strength continue?
A hyper-bullish breakaway gap supports positive price action in this leading biotech stock. The post Biotech Stock Finds Favor Amongst Mutual Fund Managers appeared first on Investor's Business Daily.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE